Natural herb ‘Chhoti Kateli’ prevents Tuberculosis effectively: Acharya Balkrishna
Patanjali’s research on TB has been published in ‘Frontiers in Microbiology’ journal
Thursday, 18 July 2024 | PNS | HARIDWAR
While addressing a programme here on Wednesday, Acharya Balkrishna said that a recent study conducted at Patanjali has highlighted the potential of Solanum virginianum Extract (SVE) or ‘Chhoti Kateli’ as anti-tubercular therapy. “This research is part of an initiative aimed at developing herbal therapies that can either stand alone or complement existing anti-TB drugs with defined mechanisms of action and herb-drug synergism,” he said. He further said that that this Patanjali research has been published in the renowned peer-reviewed journal ‘Frontiers in Microbiology’, adding that this groundbreaking research has laid the foundation for future studies on the anti-mycobacterial properties of Chhoti Kateli extract, offering new hope in combating tuberculosis.
Invoking the WHO, he said that over one crore people had been affected across the world in 2022 by this deadly disease. “Despite being a preventable and curable disease, many people die from TB each year, making it the world’s one of the top infectious killers,” he said.
“Worryingly, the current treatment modalities include the limited bio availability of anti-tubercular drugs and the propensity of the bacteria to develop single or multi-drug resistant. Besides, the long treatment period of anti-tubercular drugs induces drug-associated hepatotoxicity. All this makes it apparent that there is a desperate need for new TB drugs or adjunct therapy that makes the existing line of treatment more effective,” he said and added that as per the current study, an investigation of Mycobacterium tuberculosis (Mtb) showed that the bacteria when treated with SVE exhibited reduced growth and viability, indicating the extract’s anti-tubercular effects.
Reiterating Patanjali’s commitment to spreading the knowledge and science of Ayurveda globally to liberate people from curable and incurable diseases, he said that all the scientists and employees at Patanjali are driven by the goal of reviving the golden era of Ayurveda and ensuring that India’s ancient heritage resonates worldwide.
